arsenic trioxide has been researched along with Sclerosis, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Allanore, Y; Avouac, J; Cauvet, A; Decellas, A; Guignabert, C; Ottaviani, M; Rieger, F; Rongvaux-Gaïda, D; Thuillet, R; Tu, L | 1 |
| Batteux, F; Chéreau, C; Kavian, N; Laude, H; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
| Batteux, F; Borderie, D; Chéreau, C; Dupin, N; Kavian, N; Lemaréchal, H; Marut, W; Nicco, C; Servettaz, A; Weill, B | 1 |
3 other study(ies) available for arsenic trioxide and Sclerosis, Systemic
| Article | Year |
|---|---|
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.
Topics: Animals; Arsenic Trioxide; Disease Models, Animal; Humans; Mice; Scleroderma, Localized; Scleroderma, Systemic; Vascular Remodeling | 2023 |
Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
Topics: Animals; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Chronic Disease; Disease Models, Animal; Female; Fibrosis; Graft vs Host Disease; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxides; Random Allocation; Scleroderma, Systemic; Spleen | 2012 |
Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis.
Topics: Animals; Arsenic Trioxide; Arsenicals; Autoantibodies; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Glutathione; Interleukin-13; Interleukin-4; Mice; Oxides; Reactive Oxygen Species; Scleroderma, Systemic; Skin; Vascular Cell Adhesion Molecule-1 | 2012 |